excellent find indeed.. seems we are on the right track .. i would say Geron probably ops in and shares the cost and will benefit more in the end with the higher Royalties right? is that the idea of option in or out?
actually i just looked it up and this is even on their website
In an effort to advance Oncophage® toward commercialization in Russia, Agenus granted NewVac LLC (a subsidiary of ChemRar Ventures) an exclusive license to manufacture, market, and sell Oncophage® as well as pursue a development program in the Russian Federation and certain other CIS countries. NewVac is in the process of establishing manufacturing capabilities in Russia and completion is anticipated in 2014."
we never heard anything of this again .. weird
partner for prophage is what they are waiting for .. also .. didn't we have prophage approved in Russian a few years ago . ..and nothing ever happened
only way i see the shorts stopping is with an approval or fast track .. .and or with something else in the pipeline.. so they cant continue to tell analysts that they only have one drug and if it fails .. then they are in deep doodoo........... I personally think Imet will get approved and i own alot... but just being realistic.. and i think Scarlett knows this .. so he is threatening with doing same.. .. so unlike others on this board i would be happy to see they buy other company or jv on other drugs or combos
Wow very long and detailed presentation .. very imformative and i believe imho if i may say quite bullish ..
too much to recap right now ..
The whole thing so far is very impressive.. the material and depth .. im happy ive stuck with them through the years.... bravo .. Garo